This inventor holds 1 USPTO granted patent. Top assignee: Kyowa Hakko Kogyo Co., Ltd.. Active years: 1982.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1982
Title: The Innovations of Yuzura Matsuda: A Pioneer in Antibacterial Compounds
Introduction
Yuzura Matsuda, an inventive mind hailing from Koganei, Japan, has made significant contributions to the field of microbiology and pharmaceutical development. With a focus on novel antibacterial solutions, Matsuda has secured a notable patent that highlights his expertise and innovative approach in addressing microbial challenges.
Latest Patents
Matsuda holds a patent for the innovative compound DC-38-V, which is produced through the cultivation of a microorganism belonging to the genus Streptomyces. This antibacterial compound represents a breakthrough in combating bacterial infections, showcasing Matsuda's commitment to advancing medical science through effective solutions.
Career Highlights
Yuzura Matsuda has established his career primarily at Kyowa Hakko Kogyo Co., Ltd., a leading company in biotechnology and pharmaceuticals. His work at this organization has allowed him to explore the potential of natural compounds, leading to significant discoveries that benefit public health and safety.
Collaborations
Throughout his career, Matsuda has collaborated with talented professionals, including colleagues Fusao Tomita and Kunikatsu Shirahata. These collaborations have fostered a collaborative environment that is essential for innovation and the development of novel pharmaceutical products.
Conclusion
Yuzura Matsuda's contributions to the field of antibacterial compounds are a testament to his inventive spirit and dedication. His patent for the compound DC-38-V not only reflects his innovative capabilities but also his role in advancing healthcare solutions. As he continues to work with Kyowa Hakko Kogyo Co., Ltd., the impact of his research and discoveries is poised to extend further, benefiting society at large.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
